Emerging Regenerative Medicine Technology Working Group

ISCT Emerging Regenerative Medicine Technology Working Group

Charter

The Emerging Regenerative Medicine Technology (ERMT) Working Group is an ISCT Process Development & Manufacturing Committee sub-committee.

Goal

  • Discuss the process development, IP, commercialization and freedom to operate logistics of innovative, emerging regenerative medicine technology.

Projects & Objectives

  • The Working Group is currently exploring iPSC technology 
  • Webinar: ERMT aims to create a presentation focused on the use of iPSC technology in the field. 
  • White papers: ERMT is curating a paper on the technology available to reprogram, expand and differentiate iPSCs. The publication is estimated for 2023.


    The 2022 Roster

    Headshot of Shannon Eaker

    Co-Chair

    Julie Allickson, PhD

    Mayo Clinic
    United States

    Headshot of Uma L

    Co-Chair

    Uma Lakshmipathy, PhD

    Thermo Fisher
    United States

    Kapil Bharti
    The National Institutes of Health
    United States

    Christopher Bravery 
    Advbiols 
    United Kingdom

    Emanuelle Cameau
    Pall
    France

    Nisha Durand
    Mayo Clinic
    United States

    Ryan Hicks
    AstraZeneca
    United Kingdom

    Matthew Marsh 
    Minaris Regenerative Medicine
    Germany

    Fernanda Masri
    Catapult
    United Kingdom

    Sam Molina
    Principal
    United States

    Brianna Schoen
    Charles River
    United States

    Cenk Sumen
    MaxCyte
    United States